Skip to Content

Recently, I finished reading The Gene:  An Intimate History by Siddhartha Mukherjee, MD. Scribner, 2016. 596 pages. Most of us in Cancer Land are familiar with Mukherjee’s acclaimed 2011 Pulitzer prize-winning book, The Emperor of All Maladies. The latter was made into a PBS documentary. You can read my review of that four-part television series here. …

Read More about “The Gene: An Intimate History” by Siddhartha Mukherjee – A Review & Giveaway

I’m pleased to share the next #MetsMonday featured post by Mary S. Foti. This one covers a lot of ground. Mary shares about being a caregiver for her mother, being diagnosed with breast cancer herself, discovering she is BRCA2+, loss, survivor guilt, her advocacy work regarding EOL choices and yes, being told she had the …

Read More about “The Good Kind” (of Cancer) – A #MetsMonday Featured Post by Mary S. Foti

The recent announcement by 23andMe, stating it now has FDA authorization to report on three specific BRCA1 and BRCA2 breast cancer gene mutations associated with breast, ovarian and prostate cancer via direct-to-consumer (DTC) testing, stirred up debate. Since reading about this announcement, I’ve been mulling over my thoughts on it. 

Read More about FDA Will Allow 23andMe to Offer DTC Test for Three BRCA Gene Mutations – Good or Bad Idea?